Viridian Therapeutics Inc (VRDN)
12.78
+0.47
(+3.82%)
USD |
NASDAQ |
Jun 27, 16:00
12.77
-0.01
(-0.08%)
After-Hours: 20:00
Viridian Therapeutics Enterprise Value: 422.50M for June 27, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 27, 2024 | 422.50M |
| June 26, 2024 | 392.51M |
| June 25, 2024 | 421.23M |
| June 24, 2024 | 449.95M |
| June 21, 2024 | 409.10M |
| June 20, 2024 | 396.97M |
| June 18, 2024 | 384.21M |
| June 17, 2024 | 385.49M |
| June 14, 2024 | 400.80M |
| June 13, 2024 | 446.12M |
| June 12, 2024 | 414.84M |
| June 11, 2024 | 465.90M |
| June 10, 2024 | 386.76M |
| June 07, 2024 | 383.57M |
| June 06, 2024 | 387.40M |
| June 05, 2024 | 394.42M |
| June 04, 2024 | 347.19M |
| June 03, 2024 | 372.72M |
| May 31, 2024 | 369.53M |
| May 30, 2024 | 368.89M |
| May 29, 2024 | 371.44M |
| May 28, 2024 | 384.85M |
| May 24, 2024 | 379.74M |
| May 23, 2024 | 382.93M |
| May 22, 2024 | 417.40M |
| Date | Value |
|---|---|
| May 21, 2024 | 428.88M |
| May 20, 2024 | 470.37M |
| May 17, 2024 | 465.26M |
| May 16, 2024 | 540.57M |
| May 15, 2024 | 517.60M |
| May 14, 2024 | 543.13M |
| May 13, 2024 | 522.07M |
| May 10, 2024 | 493.98M |
| May 09, 2024 | 494.62M |
| May 08, 2024 | 557.81M |
| May 07, 2024 | 573.12M |
| May 06, 2024 | 601.84M |
| May 03, 2024 | 589.72M |
| May 02, 2024 | 537.38M |
| May 01, 2024 | 488.24M |
| April 30, 2024 | 453.14M |
| April 29, 2024 | 474.84M |
| April 26, 2024 | 428.88M |
| April 25, 2024 | 417.40M |
| April 24, 2024 | 438.46M |
| April 23, 2024 | 516.32M |
| April 22, 2024 | 519.17M |
| April 19, 2024 | 538.31M |
| April 18, 2024 | 574.04M |
| April 17, 2024 | 568.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-9.826M
Minimum
Sep 27 2019
1.275B
Maximum
Jan 26 2023
373.04M
Average
300.11M
Median
Oct 28 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 486.45M |
| Electromed Inc | 113.10M |
| Xtant Medical Holdings Inc | 106.21M |
| Asensus Surgical Inc | 81.77M |
| Myomo Inc | 76.06M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -48.54M |
| Revenue (Quarterly) | 0.072M |
| Total Expenses (Quarterly) | 55.97M |
| EPS Diluted (Quarterly) | -0.79 |
| Profit Margin (Quarterly) | -67.42K% |
| Earnings Yield | -35.21% |
| Normalized Earnings Yield | -35.21 |